;)For Laboratories

Pursue LDT Revenue Cycle Success with Cross-functional Collaboration

In many traditional lab organizations, the scientific product development group has historically produced new diagnostic tests without meaningful input and consideration of payer policy and revenue cycle demands. But what if the lab were to begin considering the needs of the revenue cycle even earlier? What if revenue cycle considerations were included in the lab’s decision-making […]

Continue Reading...

Quadax Presents Strategic Considerations for Managing the Increasing Patient Cost-Share Trend

CLEVELAND, January 14, 2019 – Quadax Inc., a healthcare information technology leader in providing revenue cycle optimization software and services, will present strategies for laboratories to improve collections and reduce administrative burden at the 14th Semi-Annual Q1 Diagnostic Coverage & Reimbursement Conference West. The conference takes place at the Hilton Garden Inn San Diego Bayside from […]

Continue Reading...

14 Day Rule Regarding ADLT and MolPath Tests Continues to Show Movement

Movement continues on CMS reimbursement of Advanced Diagnostic Laboratory Tests (ADLTs) and Molecular Pathology testing during the 14 days following a hospital stay. Recently it was announced that CMS will exercise enforcement discretion until January 2, 2019, for the laboratory date of service (DOS) exception policy for ADLTs and molecular pathology tests excluded from Hospital Outpatient […]

Continue Reading...

Quadax Introduces Prior Authorization Management Service to Streamline the Authorization Process for Labs

CLEVELAND, Aug. 7, 2018 – At this year’s 2018 Next Generation Dx Summit taking place at the Grand Hyatt Washington from August 20-24, 2018, Quadax will introduce its Prior Authorization Management Service to help laboratory departments streamline the authorization process to grow revenue, decrease claim denials, reduce administrative costs and gain visibility into operational and financial performance. @QuadaxInc […]

Continue Reading...

Prior Authorization – The Lab’s Dilemma

How are some of the payers’ Prior Authorization (PA) programs impacting your laboratory’s bottom line and what can you do about it? Increasingly, retroactive authorization after performing lab tests is becoming a less viable option; as is fighting denials for lack of Prior Authorization during the appeal process. While some payers still allow retroactive authorization, […]

Continue Reading...
Search quadax